Breast Cancer, Ovarian Cancer, Research and Clinical Trials

Faye Belvin: Living a healthy life, thanks to a phase I clinical trial

By Nicole Ferrara • July 5, 2022
Estimated reading time: 1 minute

Faye Belvin, a 58-year-old woman from Jacksonville, FL, was diagnosed and successfully treated for ovarian cancer in 2021 after having been treated for breast cancer in 2020. Her treatment included a phase I clinical trial at Mayo Clinic. Her story was highlighted by the American Association for Cancer Research Cancer Disparities Progress Report 2022. Read more of Faye's story here.

Learn more

Learn why cancer clinical trials are important.

Find a clinical trial and learn more about participating in clinical trials and research at Mayo Clinic.

American Association of Cancer Research Breast Cancer cancer clinical trials Cancer Disparities Progress Report 2022 Faye Belvin Ovarian Cancer Research and Clinical Trials
Subscribe
Request an Appointment
Find a Clinical Trial
Breakthrough in treatment approach showing promise in the fight against glioblastoma

Short-course hypofractionated proton beam therapy incorporating advanced imaging may improve overall survival over standard radiation therapy in people over 65 with grade 4 malignant glioblastoma.

Research shows new treatment could delay cancer progression in patients with high-risk smoldering multiple myeloma

Daratumumab, a monoclonal antibody drug, significantly reduces the risk of progression to active multiple myeloma and improves overall survival compared to active monitoring.

Novel oncolytic immunotherapy shows promise for people with bladder cancer

Study demonstrates potentially effective treatment for people with bladder cancer who no longer respond to Bacillus Calmette-Guérin (BCG).